Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Microfluidic Devices Capture and Analyze Single Cancer Cells

Abstract:
One of the grand goals in nanotechnology is to develop a single microfluidic device that integrates all of the components needed to perform polymerase chain reaction (PCR)-based nucleic acid analyses. Experts predict that such a device would enable researchers to develop rapid assays for cancer and other life-threatening diseases while a patient is in the doctor's office.

Microfluidic Devices Capture and Analyze Single Cancer Cells

Bethesda, MD | Posted on January 17th, 2009

A team of investigators at the University of California, Berkeley not only has built such a device, but also has used it to measure changes in gene expression in individual cells following treatment with an agent designed to silence gene expression. The device features four distinct regions that capture single cells, break them apart, amplify the messenger RNA (mRNA) from the cells using reverse-transcriptase PCR, and then analyze and quantify the amplified nucleic acids. The team, led by Richard Mathies, Ph.D., and Carolyn Bertozzi, Ph.D., describes its new device in the journal Proceedings of the National Academy of Sciences of the United States of America.

Four complete devices reside on a glass wafer that is a mere 100 millimeters in diameter. A complete analysis, from cell capture to data output, takes less than 75 minutes. A fully integrated capillary electrophoresis system—a miniaturized version of a standard PCR analysis setup—is incorporated in each device and yields data in a format readily interpretable by anyone with PCR experience. The researchers note that the device should be capable of measuring the expression of 5 to 10 different genes simultaneously.

As a test of the device's capabilities, the researchers analyzed gene expression by Jurkat T-lymphocyte cells that were first treated with a small interfering RNA (siRNA) agent designed to reduce production of a protein known as GAPDH. When the cells were analyzed in bulk, using standard methods, the results showed that siRNA treatment reduced GAPDH expression to 21% of its original value before treatment. However, an analysis of individual cells showed that there were two populations of cells, one of which experienced complete silencing of GAPDH, whereas the other showed moderate gene silencing in which protein expression was cut in half.

One of main limitations of this device is that it uses a biochemical "trick" to capture cells. This trick involves growing the cells of interest in a special growth medium that enables the cell to present a specific chemical group on their cell membranes. This chemical group acts as a tether that can be used to capture the cells inside the microfluidic device. However, research by Weihong Tan, Ph.D., and his colleagues at the University of Florida details a different approach for capturing specific types of cancer cells, which could be used with the integrated mRNA analyzer.

Reporting its work in the journal Analytical Chemistry, Dr. Tan's group describes its use of aptamers to capture cancer cells in a microfluidic device. Aptamers are short, chemically synthesized pieces of DNA or RNA that bind strongly to protein targets, much like antibodies. Using the standard aptamer discovery technology known as SELEX, the researchers are able to quickly identify aptamers that bind to a specific cell type—in this case acute lymphocytic leukemia cells—while ignoring all others. The investigators then immobilized this aptamer on the surface of a microfluidic channel and used it to capture about 80 percent of the target cells in a mixture of cells. The purity of the captured cells was over 97%.

####

About National Cancer Institute
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.

Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.

For more information, please click here

Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580

Copyright © National Cancer Institute

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

View abstract - “Integrated microfluidic bioprocessor for single-cell gene expression analysis.”

View abstract - “Enrichment of cancer cells using aptamers immobilized on a microfluidic channel.”

Related News Press

News and information

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Microfluidics/Nanofluidics

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

Heat-Based Technique Offers New Way to Measure Microscopic Particles March 13th, 2014

New partnership between Malvern Instruments and RheoSense brings m-VROCi to industrial markets February 28th, 2014

Nanomedicine

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Announcements

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE